· rebuilt nightly from public records
Signal Sheet
Headquartered in Ponte Vedra, Florida, Cadrenal Therapeutics is a publicly listed pharmaceutical preparations company, founded 2022. It raised $8.8M in Jun 2026 and its filings name 13 officers. Everything below links to the record it came from.
The easy button for new customers
Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.
Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.
The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names
| Role | Contact | Source | Why they matter now |
|---|---|---|---|
| Executive Officer | Quang X. Pham | SEC filing, Jun 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | John P. Sharp | SEC filing, Jun 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | James J. Ferguson | SEC filing, Jun 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | Jeffrey S. Cole | SEC filing, Jun 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | Matthew Szot | SEC filing, Apr 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | James Ferguson | SEC filing, Apr 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | Jeffrey Cole | SEC filing, Apr 2026 | Named officer in the filing; part of the buying group |
| Executive Officer | Matthew K. Szot | SEC filing, Dec 2025 | Named officer in the filing; part of the buying group |
| Chief Technology Officer | Lee Golden | SEC filing, Jun 2026 | Technology and tooling decisions |
| Chief Technology Officer | John R. Murphy | SEC filing, Jun 2026 | Technology and tooling decisions |
| Chief Technology Officer | Glynn Wilson | SEC filing, Jun 2026 | Technology and tooling decisions |
| Chief Technology Officer | Steven Zelenkofske | SEC filing, Apr 2026 | Technology and tooling decisions |
| Chief Technology Officer | Lee S. Golden | SEC filing, Dec 2025 | Technology and tooling decisions |
Officer or director change
New leadershipEquity raise reported to the SEC, Jun 2026. Money arrives before the spending plan does.
Capital3 equity raises in 6 months. Repeat funding is a company buying for growth, not maintenance.
PatternThe most recent events first, refreshed every night. Each links to the record it came from.
| When | What happened | Kind | Source |
|---|---|---|---|
| Sep 24, 2026 | Officer or director change | New leadership | SEC filing |
| Jun 30, 2026 | Raised $8.8M in equity from 1 investors | Capital | SEC filing |
| Apr 1, 2026 | Raised $7.9M in equity from 1 investors | Capital | SEC filing |
| Dec 16, 2025 | Raised $4.4M in equity from 4 investors | Capital | SEC filing |
Lakewave finds the right people at Cadrenal Therapeutics, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.
Try it on Cadrenal Therapeutics with a free trial →| Headquarters | Ponte Vedra, Florida, per the filing address |
| Industry group | Pharmaceutical Preparations |
| Founded | 2022, DE |
| Ownership | Listed company |
| Raise history | $4.4M (Dec 2025) · $7.9M (Apr 2026) · $8.8M (Jun 2026) |
| Lakewave Rising | 8 · 2 kinds of evidence · rank in Florida after sign-up |
Private-sector companies in the same industry group and state, ranked by Rising score.
Yes. Cadrenal Therapeutics reported a $8.8M equity raise to the SEC on Jun 30, 2026 with 1 investors.
The company's SEC filing, Jun 2026 names Quang X. Pham (Executive Officer) among its officers.
Ponte Vedra, Florida, per the address on its SEC filing.
Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.
Start your free trialCompiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.